Skip to main content
OpenTrials
Completed

NCT Number: NCT05411835

Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Oregon Health & Science University

Portland, Oregon, 97239, United States

About this study

Purpose: Subjects with long-chain fatty acid oxidation disorders (LC-FAOD) do not make ketones during fasting or with exercise. Ketones are an important alternative energy substrate during moderate exercise, sparing the oxidation of glucose and providing a source of ATP to the central nervous system and exercising muscle. Fatty acid oxidation in the liver is required to make ketones. Subjects with a LC-FAOD cannot generate ketones because of their block in fatty acid oxidation during exercise. Providing ketones in an oral ketone beverage may increase blood ketones with exercise to levels normally observed in humans.

Aim: To determine the safety and tolerability of an oral ketone beverage during moderate intensity exercise among subjects with a LC-FAOD compared to an isocaloric maltodextrin beverage, and to determine blood ketone concentrations.

Hypothesis: Oral consumption of a ketone beverage before moderate intensity exercise will be safe and well-tolerated, and will raise blood ketones among subjects with a LC-FAOD to concentrations similar to that reported in the literature among normal healthy subjects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • confirmed diagnosis of VLCAD, LCHAD/TFP or CPT2 deficiency
  • speak English
  • willing to complete 2 moderate intensity exercise treadmills

Exclusion criteria

  • subjects actively participating in another research study that prohibits their participation
  • pregnant females
  • subjects with diabetes or taking medications to treat diabetes

Treatment and study plan

Nutritional Ketone Supplement

Dietary Supplement

Mix of sodium, calcium, and magnesium salts of D-beta-hydroxybutyrate with nicotinamide riboside chloride, flavors and stevia sweetener

Other names: NKS

Isocaloric placebo supplement

Dietary Supplement

Maltodextrin with flavors and stevia sweetener

Primary outcomes

  1. Adverse Events- incidence

    Time frame: 2 hours after product intake

    Number of Adverse events

  2. Adverse Events- type

    Time frame: 2 hours after product intake

    Description of Adverse events: categorical

  3. Adverse Events- severity

    Time frame: 2 hours after product intake

    Severity of adverse event: grade 1-5

  4. Adverse Events- causal relationship

    Time frame: 2 hours after product intake

    Yes/No related to product intake

  5. Abdominal discomfort

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

  6. Decreased appetite

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

  7. Gastric reflux

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

  8. Nausea

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

  9. Diarrhea

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

  10. Headache

    Time frame: 2 hours after product intake

    visual analogue scale (VAS) 0-10

Secondary outcomes

  1. Blood Ketones

    Time frame: 20 minutes after moderate intensity exercise

    plasma beta-hydroxybutyrate concentration

  2. Blood Creatine Kinase

    Time frame: 20 minutes after moderate intensity exercise

    plasma CK concentration

  3. Blood Glucose

    Time frame: 20 minutes after moderate intensity exercise

    serum glucose

  4. Blood Lactate

    Time frame: 20 minutes after moderate intensity exercise

    serum lactate concentration

  5. Blood Pressure

    Time frame: peak 40 minute exercise

    diastolic BP

  6. Blood Pressure

    Time frame: peak 40 minute exercise

    systolic BP

  7. Perceived exertion

    Time frame: peak 40 minute exercise

    Borg scale 1-20

  8. Respiratory Exchange Ratio

    Time frame: peak 40 minute exercise

    VCO2/VO2 0.7 - 1.0

  9. Heart Rate

    Time frame: peak 40 minute exercise

    beats per minute

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Registry information

Official study title

Safety and Tolerability of Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Jun 9, 2022
Registry last updated
Apr 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.